Onconic Therapeutics Inc. (KOSDAQ:476060)

South Korea · Delayed Price · Currency is KRW

27,300

-600 (-2.15%)

Jul 21, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
License	19.65B	Log In	Log In
Services	1.40B	Log In	Log In
Services Growth	-98.52%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	21.06B	Log In	Log In
South Korea Growth	22064.25%	Log In	Log In